(3) In addition, when detecting AKI biomarkers by aptamers, more novel proteins can be selected as targets, such as kidney injury molecule-1 (KIM-1) which outperforms NGAL and cysC mainly adopted in this article in AKI early diagnosis. This evidence concerns the gene LCN2 and acute kidney injury.